These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29029766)

  • 1. Diagnostic performance of gadofosveset-enhanced axillary MRI for nodal (re)staging in breast cancer patients: results of a validation study.
    van Nijnatten TJA; Schipper RJ; Lobbes MBI; van Roozendaal LM; Vöö S; Moossdorff M; Paiman ML; de Vries B; Keymeulen KBMI; Wildberger JE; Smidt ML; Beets-Tan RGH
    Clin Radiol; 2018 Feb; 73(2):168-175. PubMed ID: 29029766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive nodal staging in patients with breast cancer using gadofosveset-enhanced magnetic resonance imaging: a feasibility study.
    Schipper RJ; Smidt ML; van Roozendaal LM; Castro CJ; de Vries B; Heuts EM; Keymeulen KB; Wildberger JE; Lobbes MB; Beets-Tan RG
    Invest Radiol; 2013 Mar; 48(3):134-9. PubMed ID: 23262788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of standard breast MRI compared to dedicated axillary MRI for assessment of node-negative and node-positive breast cancer.
    Samiei S; Smidt ML; Vanwetswinkel S; Engelen SME; Schipper RJ; Lobbes MBI; van Nijnatten TJA
    Eur Radiol; 2020 Aug; 30(8):4212-4222. PubMed ID: 32221685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
    Lambregts DM; Beets GL; Maas M; Kessels AG; Bakers FC; Cappendijk VC; Engelen SM; Lahaye MJ; de Bruïne AP; Lammering G; Leiner T; Verwoerd JL; Wildberger JE; Beets-Tan RG
    Ann Surg; 2011 Mar; 253(3):539-45. PubMed ID: 21239980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of gadofosveset-enhanced MRI and multiplanar reformatting for selecting good responders after chemoradiation for rectal cancer.
    Heijnen LA; Maas M; Lahaye MJ; Lalji U; Lambregts DM; Martens MH; Riedl RG; Beets GL; Beets-Tan RG
    Eur Radiol; 2014 Aug; 24(8):1845-52. PubMed ID: 24898096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.
    Schipper RJ; Paiman ML; Beets-Tan RG; Nelemans PJ; de Vries B; Heuts EM; van de Vijver KK; Keymeulen KB; Brans B; Smidt ML; Lobbes MB
    Radiology; 2015 May; 275(2):345-55. PubMed ID: 25513854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients.
    van Nijnatten TJA; Ploumen EH; Schipper RJ; Goorts B; Andriessen EH; Vanwetswinkel S; Schavemaker M; Nelemans P; de Vries B; Beets-Tan RGH; Smidt ML; Lobbes MBI
    Eur J Radiol; 2016 Dec; 85(12):2288-2294. PubMed ID: 27842679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Fused Diffusion-Weighted Imaging Using T1-Weighted Imaging for Axillary Nodal Staging in Patients With Early Breast Cancer.
    Kim SH; Shin HJ; Shin KC; Chae EY; Choi WJ; Cha JH; Kim HH
    Clin Breast Cancer; 2017 Apr; 17(2):154-163. PubMed ID: 27843006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance of gadofosveset-enhanced MRI for staging rectal cancer nodes: can the initial promising results be reproduced?
    Heijnen LA; Lambregts DM; Martens MH; Maas M; Bakers FC; Cappendijk VC; Oliveira P; Lammering G; Riedl RG; Beets GL; Beets-Tan RG
    Eur Radiol; 2014 Feb; 24(2):371-9. PubMed ID: 24051676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of preoperative breast magnetic resonance imaging with a dedicated axillary sequence for the detection of axillary lymph node metastasis in patients with early ductal breast cancer.
    Ahn HS; Jang M; Kim SM; La Yun B; Lee SH
    Radiol Med; 2019 Dec; 124(12):1220-1228. PubMed ID: 31422573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound.
    Abe H; Schacht D; Kulkarni K; Shimauchi A; Yamaguchi K; Sennett CA; Jiang Y
    Acad Radiol; 2013 Nov; 20(11):1399-404. PubMed ID: 24119352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    van Nijnatten TJA; Goorts B; Vöö S; de Boer M; Kooreman LFS; Heuts EM; Wildberger JE; Mottaghy FM; Lobbes MBI; Smidt ML
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):179-186. PubMed ID: 28905091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes.
    Murray AD; Staff RT; Redpath TW; Gilbert FJ; Ah-See AK; Brookes JA; Miller ID; Payne S
    Br J Radiol; 2002 Mar; 75(891):220-8. PubMed ID: 11932214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
    Samiei S; van Nijnatten TJA; van Beek HC; Polak MPJ; Maaskant-Braat AJG; Heuts EM; van Kuijk SMJ; Schipper RJ; Lobbes MBI; Smidt ML
    Sci Rep; 2019 Nov; 9(1):17476. PubMed ID: 31767929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
    Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
    Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria.
    Lambregts DM; Heijnen LA; Maas M; Rutten IJ; Martens MH; Backes WH; Riedl RG; Bakers FC; Cappendijk VC; Beets GL; Beets-Tan RG
    Abdom Imaging; 2013 Aug; 38(4):720-7. PubMed ID: 22986353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results.
    Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A
    AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients.
    Hyun SJ; Kim EK; Yoon JH; Moon HJ; Kim MJ
    Clin Radiol; 2015 Jul; 70(7):716-22. PubMed ID: 25917544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superparamagnetic iron oxide-enhanced MRI at 3 T for accurate axillary staging in breast cancer.
    Motomura K; Izumi T; Tateishi S; Tamaki Y; Ito Y; Horinouchi T; Nakanishi K
    Br J Surg; 2016 Jan; 103(1):60-9. PubMed ID: 26572241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.